[1]
Kruger, S. et al. 2015. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. Acta Oncologica. 54, 7 (Aug. 2015), 993–1000. DOI:https://doi.org/10.3109/0284186X.2015.1034877.